{"id":1635,"date":"2022-11-29T16:41:52","date_gmt":"2022-11-29T22:41:52","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=1635"},"modified":"2022-12-13T11:21:09","modified_gmt":"2022-12-13T17:21:09","slug":"blood-thinner-ineffective-for-covid-19-patients-study","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/11\/29\/blood-thinner-ineffective-for-covid-19-patients-study\/","title":{"rendered":"Blood Thinner Ineffective for COVID-19 Patients: Study"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p>(<a href=\"https:\/\/www.the-scientist.com\/news-opinion\/blood-thinner-ineffective-for-covid-19-patients-study-70793\">The Scientist<\/a>) A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous. New data from a clinical trial suggest that apixaban, an anticoagulant that\u2019s widely been prescribed to promote recovery in patients with severe cases of COVID-19, doesn\u2019t offer any discernable benefit for people with the disease. <a href=\"https:\/\/www.bbc.com\/news\/uk-england-cambridgeshire-63761765\">Related BBC Article<\/a><\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>(The Scientist) A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous. New data from a clinical trial suggest that apixaban, an anticoagulant that\u2019s widely been prescribed to promote recovery in patients with severe cases of COVID-19, doesn\u2019t offer any discernable [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[13],"tags":[],"class_list":["post-1635","post","type-post","status-publish","format-standard","hentry","category-clinical-considerations"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=1635"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1635\/revisions"}],"predecessor-version":[{"id":1636,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1635\/revisions\/1636"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=1635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=1635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=1635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}